Amyotrophic Lateral Sclerosis
Overview and clinical definition are open. Full Step 1 details unlock with a plan.
For the why behind the fact
Use this page to connect what you are memorizing.
Start with the overview when a class slide, Anki card, or qbank explanation feels too thin. Then use presentation and workup to recognize the condition, and differentials to separate look-alikes.
Overview
Plain-Language Overview
Amyotrophic lateral sclerosis (ALS) damages nerve cells controlling voluntary muscles, causing progressive weakness and difficulties with movement, speech, swallowing and breathing. It usually affects both upper and lower motor neurons. Sensation is generally preserved, but some people develop changes in thinking, language or behavior, including frontotemporal dementia. The pattern and speed of progression vary.
Clinical Definition
Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by the selective loss of both upper motor neurons in the motor cortex and lower motor neurons in the brainstem and spinal cord. The core pathology involves motor neuron degeneration leading to muscle atrophy, weakness, and spasticity. The exact cause is often unknown but can involve genetic mutations such as in the SOD1 or C9orf72 genes. ALS results in a combination of upper motor neuron signs (spasticity, hyperreflexia) and lower motor neuron signs (fasciculations, muscle atrophy). The disease is clinically significant due to its relentless progression and fatal outcome, typically from respiratory failure within 3 to 5 years of symptom onset. Diagnosis is primarily clinical, supported by electrophysiological studies.